AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

AJPH First Look, published online ahead of print Aug 30, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
AJPH.2004.056150v1
95/10/1737    most recent
Right arrow Submit a response
Right arrow purchase articles
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Get other permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Farley, J.
Right arrow Articles by Farley, T. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Farley, J.
Right arrow Articles by Farley, T. A.
Related Collections
Right arrow Access to Care
Right arrow Hepatitis
Right arrow Prevention
Right arrow Public Health Practice
Right arrow Men's Health
Right arrow Drugs
October 2005, Vol 95, No. 10 | American Journal of Public Health 1737-1739
© 2005 American Public Health Association
DOI: 10.2105/AJPH.2004.056150

RESEARCH AND PRACTICE

Feasibility and Outcome of HCV Treatment in a Canadian Federal Prison Population

John Farley, MD, Shawn Vasdev, MEd, Benedikt Fischer, PhD, Emma Haydon, BSc, Jürgen Rehm, PhD and Theresa A. Farley, BA

John Farley is with the University of British Columbia and John Farley, Inc, Vancouver, British Columbia. Shawn Vasdev is with University of Ottawa, Ottawa, Ontario. Benedikt Fischer, Emma Haydon, and Jürgen Rehm are with Centre for Addiction and Mental Health and University of Toronto, Toronto, Ontario. Jürgen Rehm is also with Addiction Research Institute, Zurich, Switzerland. Theresa A. Farley is with John Farley, Inc, Vancouver.

Correspondence: Requests for reprints should be sent to Benedikt Fischer, PhD, Centre for Addiction and Mental Health, 33 Russell St, Room 2035, Toronto, Ontario, Canada M5S 2S1 (e-mail: benedikt_fischer{at}camh.net).

We assessed feasibility and outcome of hepatitis C virus (HCV) treatment in male correctional inmates in British Columbia, Canada. We reviewed the medical charts of 114 treated inmates; 80 had complete data for treatment outcome. Approximately 4 of 5 inmates completed treatment (78.8%); 66.3% achieved sustained virological response. Those who completed treatment, those with injection drug use as a risk factor, and those with genotypes 2 and 3 were significantly more likely to achieve sustained virological response. HCV treatment in correctional inmates is feasible and effective.




This article has been cited by other articles:


Home page
 J Am Acad Psychiatry LawHome page
R. L. Trestman, J. Ford, W. Zhang, and V. Wiesbrock
Current and Lifetime Psychiatric Illness Among Inmates Not Identified as Acutely Mentally Ill at Intake in Connecticut's Jails
J Am Acad Psychiatry Law, December 1, 2007; 35(4): 490 - 500.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Public Health Association